Detergent-resistant membrane microdomains in the disposition of the lipid signaling molecule anandamide
- 1 March 2006
- journal article
- review article
- Published by Springer Nature in The AAPS Journal
- Vol. 8 (1) , E95-E100
- https://doi.org/10.1208/aapsj080111
Abstract
The endogenous cannabinoid anandamide is an agonist of the cannabinoid receptors CB1 and CB2, as well as transient receptor potential vanilloid type 1 and type 4 ion channels. In recent years, there has been a great deal of interest in the cellular processes regulating the signaling of endocannabinoids such as anandamide. This is due largely to evidence that augmentation of cannabinergic tone might be therapeutically beneficial in the treatment of multiple disease states such as chronic pain, anxiety, multiple sclerosis, and neuropsychiatric disorders. Of particular interest are the cellular processes that regulate the cellular accumulation and metabolism of anandamide. Characterization of the process by which anandamide is internalized and metabolized by the cell may identify drug targets useful in the positive modulation of cannabinergic tone. Recently, we reported that detergent-resistant membrane microdomains known as lipid rafts play a role in the cellular accumulation of anandamide by mediating an endocytic process responsible for anandamide internalization. The enzyme primarily responsible for anandamide metabolism, fatty acid amide hydrolase, is excluded from lipid rafts. However, the metabolites of anandamide accumulate in these detergentresistant membrane microdomains. There is some preliminary evidence that makes it reasonable to propose that anandamide metabolites enriched in lipid rafts may act as precursors to anadamide synthesis. Overall, experimental evidence is mounting that detergent-resistant membrane microdomains such as lipid rafts may play a role in the cellular regulation of anandamide inactivation and production.Keywords
This publication has 48 references indexed in Scilit:
- Lipid rafts: A nexus for endocannabinoid signaling?Life Sciences, 2005
- Cholesterol‐dependent modulation of type 1 cannabinoid receptors in nerve cellsJournal of Neuroscience Research, 2005
- Lipid Rafts Control Signaling of Type-1 Cannabinoid Receptors in Neuronal CellsJournal of Biological Chemistry, 2005
- Comparison of Anandamide Transport in FAAH Wild-Type and Knockout Neurons: Evidence for Contributions by both FAAH and the CB1 Receptor to Anandamide UptakeBiochemistry, 2004
- D2 Dopamine Receptors Modulate Gα-Subunit Coupling of the CB1 Cannabinoid ReceptorThe Journal of Pharmacology and Experimental Therapeutics, 2004
- Characterization of an anandamide degradation system in prostate epithelial PC‐3 cells: synthesis of new transporter inhibitors as tools for this studyBritish Journal of Pharmacology, 2004
- Endocannabinoids Induce Ileitis in Rats via the Capsaicin Receptor (VR1)The Journal of Pharmacology and Experimental Therapeutics, 2003
- A new perspective on cannabinoid signalling: complimentary localization of fatty acid amide hydrolase and the CB1 receptor in rat brain.Proceedings Of The Royal Society B-Biological Sciences, 1998
- ‘Endocannabinoids’ and other fatty acid derivatives with cannabimimetic properties: biochemistry and possible physiopathological relevanceBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1998
- Formation and inactivation of endogenous cannabinoid anandamide in central neuronsNature, 1994